| Serial Number | 79350047 |
| Word Mark | AITEM |
| Filing Date | Friday, July 15, 2022 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 13, 2024 |
| Goods and Services | Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; Drugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; Drugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases |
| Goods and Services | Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 052, 051, 005, 018, 006, 044, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 20, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 20, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BEIJING JITAI PHARMACEUTICAL TECHNOLOGYCO.,LTD |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | BEIJING JITAI PHARMACEUTICAL TECHNOLOGYCO.,LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Sunday, March 17, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, February 26, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 21, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, February 19, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 13, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, January 29, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 24, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, January 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 8, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 8, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, November 19, 2023 | ASSIGNED TO EXAMINER |
| Saturday, July 22, 2023 | REFUSAL PROCESSED BY IB |
| Friday, June 23, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 22, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, May 18, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, May 17, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 2, 2023 | ASSIGNED TO EXAMINER |
| Saturday, September 24, 2022 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, September 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 16, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |